Pharma
New cannabinoid pharma and nutraceuticals
Cannabis Therapeutics to develop and launch cannabis-based drugs and nutraceuticals using its Cannabinoid-Cannabidiol (CBD) patent….
Breaking: South Dakota House Blunts GW Pharma Bill
The bill as it now stands would remove CBD from the state's definition of marijuana, and define it as a Schedule IV…
GW Pharma Moves to Potentially Monopolize CBD Market
Latest CBD Oil News. Cannabis Flourishes on Both Sides of Divided Kashmir · Hemp: The Multi-Billion Dollar Crop( Part 2) · Cosmic…
CEO targeting big pharma with his CBD oil.
iBrands Corp. IBRC Stock Message Board: CEO targeting big pharma with his CBD oil….
Big Pharma Admits Cannabis Kills Cancer… Finally!
Most recently, GW Pharmaceuticals released their findings of a phase 2 proof of concept study examining the effects of their THC +…
GW Pharma Moves to Potentially Monopolize CBD Market – New Cannabis Ventures( blog)
State seizes CBD products, often used for managing ache, from marijuana stores – Alaska Dispatch News. February 24, 2017. News & Updates ……
GW Pharma Responds: 'Not Creating a Monopoly'
GW/Greenwich says it is not opposing medical marijuana or CBD access. … Hundreds of CBD oil manufacturers exist in medical marijuana states ……
Aphios Pharma to Develop FDA-Approved, Cannabis-Based Drugs for Opioid Addiction, Epilepsy …
… President and CEO, Aphios® Pharma points out that “Fortunately, medical marijuana and its non-psychotropic component, cannabidiol (CBD) also ……
Finally, Big Pharma Admits Cannabis Kills Cancer Cells
“The findings from this well-designed controlled study suggest that the addition of a combination of THC and CBD to patients on dose-intensive ……
Gw Pharma is Moving CBD Bills on The Down Low
The bill exempts cannabidiol from the definition of marijuana and moves CBD from a state-designated Schedule I drug to a Schedule IV…
Leafly Exclusive: GW Pharma is Moving CBD Bills on the Down Low
Leafly Exclusive: GW Pharma is Moving CBD Bills on the Down Low …. “The one distinct difference with CBD oil is that…
InMed Pharma CEO Discusses Company's Cannabinoid Biosynthesis — CFN Media
While tetrahydrocannabinol ("THC") and cannabidiol ("CBD") may be the most studied, there are 90+ other cannabinoids in the plant that could be ……